Multi drug resistant cancer is associated with loss of TP53TG1 molecule

A new study by researchers at the Bellvitge Biomedical Research Institute (IDIBELL) has found a cause of multiple resistance in cancer chemotherapy. They discovered that 10% of colon and stomach tumors present wit loss of a molecule called TP53TG1. The functionof TP53TG1 is to prevent activation of YBX1 protein. Without surveillance of TP53TG1 in these …

Multi drug resistant cancer is associated with loss of TP53TG1 molecule Read More »